SCHEMBL22129247

SCHEMBL22129247

Cc1cc(C(c2ccccc2)c2ccccc2)c(N)c(C(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TACR1 P25103 3/20 0.39
▸ SLC6A2 P23975 2/20 0.37
▸ SLC6A4 P31645 2/20 0.37
▸ SLC6A3 Q01959 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ DPP4 P27487 2/20 0.36
▸ F2 P00734 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ GAA P10253 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ MGAM O43451 1/20 0.35
▸ SI P14410 1/20 0.35
▸ MGAM2 Q2M2H8 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ ACHE P22303 1/20 0.35
▸ TAAR1 Q96RJ0 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31553481 0.93 TACR1 (0.35) TACR1SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL27840493 0.90 SLC6A2 (0.41) TACR1SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL30506418 0.90 SLC6A2 (0.41) TACR1SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL31619726 0.89 MEN1 (0.38) TACR1MAPTGAALMNAMGAM
SCHEMBL28684806 0.87 SLC6A2 (0.34) TACR1SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL22044348 0.86 SLC6A2 (0.41) TACR1SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL28257073 0.86 NUDT1 (0.41) TACR1SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL26676933 0.85 ACHE (0.39) ALDH1A1MAPTGAALMNAMGAM
SCHEMBL31553477 0.84 TACR1 (0.36) TACR1SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL24452748 0.83 DPP4 (0.39) SLC6A2SLC6A4SLC6A3ALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117402193-A Chiral oxazoline-cobalt picolinite compound and synthetic method and application thereof 郑州大学 2024-01-16 — — CN claimed
CN-108250341-A The method of catalyst system and its catalysis in olefine polymerization containing metallocene compound 北京引发科技有限公司 2018-07-06 — — CN claimed
CN-102464677-B Asymmetric diimine pyridine iron or cobalt complex catalyst, and preparation method and application thereof CHINESE ACAD INST CHEMISTRY 2014-08-13 — — CN claimed
CN-121108200-B Nickel complex, preparation method, catalyst composition and application thereof, and method for copolymerization and homopolymerization of ethylene and alpha-olefin 中石油(上海)新材料研究院有限公司 2026-05-19 — — CN disclosed
CN-122036547-A Application of single-component high-efficiency imine ketone nickel catalyst in high Wen Yixi coordination (co) polymerization 安徽大学 2026-05-15 — — CN disclosed
CN-120136933-A Large steric hindrance substituent modified acenaphthylene skeleton Ni complex and synthesis method and application thereof 中国科学院化学研究所 2025-06-13 — — CN disclosed
US-20250188106-A1 SUBSTITUTED IMIDAZO[1,5-A]PYRIDINE N-HETEROCYCLIC CARBENE (NHC) LIGANDS, CATALYST COMPLEXES THEREOF, AND METHODS USING SAME RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2025-06-12 — — US disclosed
US-20240383894-A1 HETEROBIDENTATE IMIDAZO[1,5-A]PYRIDINE AND IMIDAZO[1,5-A]QUINOLINE N-HETEROCYCLIC CARBENE (NHC) LIGANDS, CATALYST COMPLEXES THEREOF, AND METHODS USING SAME UNIV RUTGERS (US) 2024-11-21 — — US disclosed
EP-4452488-A1 HETEROBIDENTATE IMIDAZO[1,5-A]PYRIDINE AND IMIDAZO[1,5-A]QUINOLINE N-HETEROCYCLIC CARBENE (NHC) LIGANDS, CATALYST COMPLEXES THEREOF, AND METHODS USING SAME Rutgers, The State University Of New Jersey (US) 2024-10-30 — — EP disclosed
CN-114057801-B 2-imine-1, 10-phenanthroline metal complex catalyst containing aromatic hydrocarbon substituent, preparation method and application 北京服装学院 2024-02-09 — — CN disclosed
CN-117402193-A Chiral oxazoline-cobalt picolinite compound and synthetic method and application thereof 郑州大学 2024-01-16 — — CN disclosed
CN-104926686-B A kind of alpha-diimine compound and comprise the metal complex of this compound, loaded article and its application 河北工业大学 2016-11-09 — — CN disclosed
CN-105482000-A Olefin polymerization catalyst as well as preparation method and application method thereof CHINA PETROLEUM & CHEM CORP 2016-04-13 — — CN disclosed
CN-104926686-A Alpha-diimine compound, metal complex and load containing compound and application thereof UNIV HEBEI TECHNOLOGY 2015-09-23 — — CN disclosed
CN-104829488-A Supported alpha-diimine metal complex, and its application in olefin polymerization UNIV TIANJIN POLYTECHNIC 2015-08-12 — — CN disclosed
CN-104804030-A Supported alpha-diimine compound and application of supported alpha-diimine compound in olefin polymerization UNIV TIANJIN POLYTECHNIC 2015-07-29 — — CN disclosed
CN-104788489-A SiO2-supported alpha-diimine compound and application of metal complex of SiO2-supported alpha-diimine compound UNIV HEBEI TECHNOLOGY 2015-07-22 — — CN disclosed
CN-104250270-A Asymmetric benzhydryl alpha-diimine nickel complex and preparation and application thereof PETROCHINA CO LTD 2014-12-31 — — CN disclosed
CN-102464677-B Asymmetric diimine pyridine iron or cobalt complex catalyst, and preparation method and application thereof CHINESE ACAD INST CHEMISTRY 2014-08-13 — — CN disclosed
CN-102180910-B Asymmetrical alpha-diimine nickel complex catalyst and preparation method and application thereof CHINESE ACAD INST CHEMISTRY 2014-03-12 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240383894-A1 HETEROBIDENTATE IMIDAZO[1,5-A]PYRIDINE AND IMIDAZO[1,5-A]QUINOLINE N-HETEROCYCLIC CARBENE (NHC) LIGANDS, CATALYST COMPLEXES THEREOF, AND METHODS USING SAME NDC1, NUDC, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 TACR1 3228/4885SLC6A2 1871/4885SLC6A4 1340/4885
US-20250188106-A1 SUBSTITUTED IMIDAZO[1,5-A]PYRIDINE N-HETEROCYCLIC CARBENE (NHC) LIGANDS, CATALYST COMPLEXES THEREOF, AND METHODS USING SAME NDC1, NUDC, PAICS TACR1 3235/4885SLC6A2 4212/4885SLC6A4 4136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback